Espinoza-Moya ME, Laberge M, Bélanger L, Chang SL, Poder TG, Moulin VJ, Germain L, Beaudoin Cloutier C, Guertin JR. Adaptation of a standardized self-reported cost questionnaire specific for the severe burn injury population (BI-CoPaQ). Burns. 2024 Dec;50(9):107204.

Légaré C, Berglund JA, Duchesne E, Dumont NA. New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target. Bioessays. 2024 Dec 26:e202400216.

Hoey S, Fogarty U, McAllister H, Puggioni A, Cloak B, Richard H, Skelly C, Laverty S. Ultrasonographic assessment of equine metacarpal cartilage thickness is more accurate than computed tomographic arthrography. Vet Radiol Ultrasound. 2025 Jan;66(1):e13444.

Touani FK, Hamouda I, Noiseux N, Hoesli C, Der Sarkissian S, Lerouge S. Injectable, cryopreservable mesenchymal stromal cell-loaded microbeads for pro-angiogenic therapy:in vitroproof-of-concept. Biomed Mater. 2025 Jan 8;20(1).

Moeun BN, Lemaire F, Smink AM, Ebrahimi Orimi H, Leask RL, de Vos P, Hoesli CA. Oxygenation and function of endocrine bioartificial pancreatic tissue constructs under flow for preclinical optimization. J Tissue Eng. 2025 Jan 23;16:20417314241284826.

Roy J, Cohen S, Sauvageau G, Ahmad I, Fournier V, Terra R, Caudrelier P, Thiant S, Thauvette G, Bambace N, Delisle JS, Lachance S, Kiss T, Bernard L, Roy DC, Veilleux O, LeBlanc R. A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients. Transplant Cell Ther. 2025 Jan;31(1):34.e1-34.e14.

Barolet AC, Magne B, Ferland K, Uzunbajakava NE, Barolet D, Germain L. Balancing act: optimizing blue light for melanogenesis while minimizing cellular damage in primary human skin cells. Front Physiol. 2025 Jan 9;15:1513054.

Deprez A, Orfi Z, Rieger L, Dumont NA. Impaired muscle stem cell function and abnormal myogenesis in acquired myopathies. Biosci Rep. 2023;43(1). doi: 10.1042/BSR20220284. PubMed PMID: 36538023.

Dagher J, Arcand C, Auger FA, Germain L, Moulin VJ. The Self-Assembled Skin Substitute History: Successes, Challenges, and Current Treatment Indications. J Burn Care Res. 2023;44(Supplement_1):S57-S64. doi: 10.1093/jbcr/irac074. PubMed PMID: 36567476; PubMed Central PMCID: PMCPMC9790893.

Claveau JS, LeBlanc R, Ahmad I, Delisle JS, Cohen S, Kiss T, et al. Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD. Transplant Cell Ther. 2023;29(1):44 e1- e9. Epub 20221102. doi: 10.1016/j.jtct.2022.10.022. PubMed PMID: 36334654

Attiogbe E, Larochelle S, Chaib Y, Mainzer C, Mauroux A, Bordes S, et al. An in vitro autologous, vascularized, and immunocompetent Tissue Engineered Skin model obtained by the self-assembled approach. Acta Biomater. 2023. Epub 20230705. doi: 10.1016/j.actbio.2023.06.045. PubMed PMID: 37419164.

Happi Mbakam C, Roustant J, Rousseau J, Yameogo P, Lu Y, Bigot A, et al. Prime editing strategies to mediate exon skipping in DMD gene. Front Med (Lausanne). 2023;10:1128557. Epub 20230525. doi: 10.3389/fmed.2023.1128557. PubMed PMID: 37305116; PubMed Central PMCID: PMC10248452.

Gerard C, Archambault AF, Bouchard C, Tremblay JP. A promising mouse model for Friedreich Ataxia progressing like human patients. Behav Brain Res. 2023;436:114107. Epub 20220908. doi: 10.1016/j.bbr.2022.114107. PubMed PMID: 36089099.